Jeito Capital co-leads $156 million oversubscribed Series B financing in Quell Therapeutics
November 29, 2021 00:05 ET
|
Jeito Capital
Jeito Capital co-leads $156 million oversubscribed Series B financing in Quell Therapeutics Quell Therapeutics is the world leader in developing engineered T-regulatory (Tregs) cell therapies for...
JEITO CAPITAL BECOMES A KEY PLAYER IN THE FINANCING OF LIFE SCIENCES IN EUROPE WITH THE CLOSING OF JEITO I AT €534 MILLION ($630 MILLION)
September 20, 2021 01:00 ET
|
Jeito Capital
JEITO CAPITAL BECOMES A KEY PLAYER IN THE FINANCING OF LIFE SCIENCES IN EUROPE WITH THE CLOSING OF JEITO I AT €534 MILLION ($630 MILLION)Jeito I exceeds target and becomes the largest European fund...
Jeito Capital becomes key investor in Alentis Therapeutics as part of $67 million Series B financing round
June 15, 2021 01:00 ET
|
Jeito Capital
Jeito Capital becomes key investor in Alentis Therapeutics as part of $67 million Series B financing round Jeito Capital selects Alentis Therapeutics as its fifth investment since launching the...
Jeito Capital leads oversubscribed $92 million Series C financing round in Pulmocide
May 27, 2021 02:00 ET
|
Jeito Capital
Jeito Capital leads oversubscribed $92 million Series C financing round in Pulmocide Jeito selects Pulmocide as its fourth investment since launching the fundPulmocide is a late-stage biopharma...
Jeito Capital leads €20 Million Investment in InnoSkel, a New Gene Therapy Company and leader in rare skeletal disorders
December 14, 2020 01:00 ET
|
Jeito Capital
Jeito Capital leads €20 Million Investment in InnoSkel, a New Gene Therapy Company and leader in rare skeletal disorders Jeito’s third international investment in H2 2020, with deep and rapidly...
Sanofi selects Jeito Capital as its first investment into a private French-based fund
November 13, 2020 01:00 ET
|
Jeito Capital
Sanofi selects Jeito Capital as its first investment into a private French-based fund Paris, France, 13 November 2020 – Jeito Capital (“Jeito”), a rapidly emerging independent investor dedicated...
Jeito Capital becomes major investor in SparingVision as part of €44.5 Million financing
October 21, 2020 01:00 ET
|
Jeito Capital
Jeito Capital becomes major investor in SparingVision as part of €44.5 Million financing Jeito Capital has selected SparingVision as its first French investment following the fund I launch in...
Jeito Capital co-leads $110 Million Series A Financing in Neogene Therapeutics
September 14, 2020 08:00 ET
|
Jeito Capital
Jeito Capital co-leads $110 Million Series A Financing in Neogene Therapeutics Neogene becomes Jeito Capital’s first investment following the fund I launch in January 2020Round co-led by Jeito...